A preclinical study investigated the combination of brachytherapy (3x8 Gy) with IT (anti-PD1, anti-CD137, and/or their respective isotype controls) in mice with subcutaneous colorectal cancer at 2 sites. The gene discussed is TNFRSF9; the disease is colorectal cancer.